Back
Editas Medicine Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
31
EDIT
Editas Medicine
Last Price:
$1.58
Seasonality Move:
-0.1%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EDIT is experiencing slight selling pressure.
Editas Medicine Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.44 | Buy |
20-day SMA: | 1.26 | Buy |
50-day SMA: | 1.47 | Buy |
200-day SMA: | 2.66 | Sell |
8-day EMA: | 1.45 | Buy |
20-day EMA: | 1.25 | Buy |
50-day EMA: | 0.84 | Buy |
200-day EMA: | 0.29 | Buy |
Editas Medicine Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.24 | Buy |
Relative Strength Index (14 RSI): | 58.7 | Buy |
Chaikin Money Flow: | -234004 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.1 - 1.44) | Buy |
Bollinger Bands (100): | (1.12 - 1.84) | Buy |
Editas Medicine Technical Analysis
Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Editas Medicine Stock
Is Editas Medicine Stock a Buy?
-
Editas Medicine share price is 1.54 while EDIT 8-day simple moving average is 1.44, which is a Buy signal.
-
The stock price of EDIT is 1.54 while Editas Medicine 20-day SMA is 1.26, which makes it a Buy.
-
Editas Medicine 50-day simple moving average is 1.47 while EDIT share price is 1.54, making it a Buy technically.
-
EDIT stock price is 1.54 and Editas Medicine 200-day simple moving average is 2.66, creating a Sell signal.
EDIT Technical Analysis vs Fundamental Analysis
Sell
31
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy or a Sell?
-
Editas Medicine stock is rated a SellThe current Editas Medicine [EDIT] share price is $1.54. The Score for EDIT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Editas Medicine Stock Info
Market Cap:
127.8M
Price in USD:
1.54
Share Volume:
1.1M
Editas Medicine 52-Week Range
52-Week High:
6.69
52-Week Low:
0.91
Sell
31
Editas Medicine (EDIT)
is a Sell
Editas Medicine Share Price Forecast
-
What is the Editas Medicine stock price today?The Editas Medicine stock price is 1.54 USD today.
-
Will EDIT stock go up or go down?Editas Medicine> share price is forecast to RISE/FALL based on technical indicators
-
Is Editas Medicine overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Editas Medicine is overvalued.
Is Editas Medicine Stock a Buy?
-
Editas Medicine share price is 1.54 while EDIT 8-day exponential moving average is 1.45, which is a Buy signal.
-
The stock price of EDIT is 1.54 while Editas Medicine 20-day EMA is 1.25, which makes it a Buy.
-
Editas Medicine 50-day exponential moving average is 0.84 while EDIT share price is 1.54, making it a Buy technically.
-
EDIT stock price is 1.54 and Editas Medicine 200-day simple moving average is 0.29, creating a Buy signal.
Fundamental Analysis of Editas Medicine
Is Editas Medicine a good investment?
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.12 per share, and an increase next year of $0.41 per share.
Technical Analysis of Editas Medicine
Should I short Editas Medicine stock?
-
EDIT Moving Average Covergence Divergence (MACD) indicator is 0.24, suggesting Editas Medicine is a Buy
-
Editas Medicine Relative Strength Index (RSI) is 58.7, which suggest Editas Medicine is overbought
-
The Bollinger Bands (25) for Editas Medicine is (1.1 - 1.44), which suggest Editas Medicine is a Buy
-
The Bollinger Bands (100) for Editas Medicine is (1.12 - 1.84), which suggest Editas Medicine is a Buy
* Editas Medicine stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.